Sawyer & Company, Inc Amgen Inc Transaction History

Sawyer & Company, Inc

$270 Million
Q3 2024

A detailed history of Sawyer & Company, Inc transactions in Amgen Inc stock. As of the latest transaction made, Sawyer & Company, Inc holds 15,939 shares of AMGN stock, worth $5.05 Million. This represents 1.9% of its overall portfolio holdings.

Number of Shares

15,939

Previous 15,862 0.49%

Holding current value

$5.05 Million

Previous $4.96 Million 3.63%

% of portfolio

1.9%

Previous 1.97%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 10, 2024	BUY	$309.38 - $337.38 $23,822 - $25,978	77 Added 0.49%	15,939 $5.14 Million
Q2 2024 Jul 31, 2024	BUY	$262.75 - $319.31 $2,364 - $2,873	9 Added 0.06%	15,862 $4.96 Million
Q1 2024 Apr 16, 2024	SELL	$268.87 - $324.56 $8 Million - $9.66 Million	-29,752 Reduced 65.24%	15,853 $4.51 Million
Q4 2023 Jan 17, 2024	BUY	$255.7 - $288.46 $7.56 Million - $8.53 Million	29,570 Added 184.41%	45,605 $4.5 Million
Q3 2023 Oct 25, 2023	BUY	$218.65 - $271.46 $38,045 - $47,234	174 Added 1.1%	16,035 $4.31 Million
Q2 2023 Jul 13, 2023	BUY	$214.27 - $253.37 $30,426 - $35,978	142 Added 0.9%	15,861 $3.52 Million
Q1 2023 Apr 19, 2023	BUY	$225.79 - $275.2 $74,736 - $91,091	331 Added 2.15%	15,719 $3.94 Million
Q4 2022 Jan 11, 2023	SELL	$229.03 - $291.01 $42,828 - $54,418	-187 Reduced 1.2%	15,388 $4.04 Million
Q3 2022 Oct 25, 2022	BUY	$224.46 - $253.15 $15,712 - $17,720	70 Added 0.45%	15,575 $3.51 Million
Q2 2022 Jul 20, 2022	SELL	$230.71 - $256.74 $161,497 - $179,718	-700 Reduced 4.32%	15,505 $3.77 Million
Q1 2022 Apr 26, 2022	BUY	$219.27 - $242.57 $48,239 - $53,365	220 Added 1.38%	16,205 $3.92 Million
Q4 2021 Jan 14, 2022	BUY	$198.88 - $227.6 $26,252 - $30,043	132 Added 0.83%	15,985 $3.6 Million
Q3 2021 Nov 03, 2021	BUY	$212.27 - $248.7 $46,699 - $54,714	220 Added 1.41%	15,853 $3.37 Million
Q2 2021 Jul 29, 2021	BUY	$233.58 - $259.14 $80,585 - $89,403	345 Added 2.26%	15,633 $3.81 Million
Q1 2021 Apr 22, 2021	BUY	$221.91 - $258.6 $65,463 - $76,287	295 Added 1.97%	15,288 $3.8 Million
Q4 2020 Jan 26, 2021	SELL	$216.38 - $257.67 $33,538 - $39,938	-155 Reduced 1.02%	14,993 $3.45 Million
Q3 2020 Oct 20, 2020	BUY	$234.65 - $260.95 $127,884 - $142,217	545 Added 3.73%	15,148 $3.85 Million
Q2 2020 Jul 31, 2020	BUY	$197.81 - $242.74 $521,229 - $639,619	2,635 Added 22.02%	14,603 $3.44 Million
Q1 2020 May 06, 2020	BUY	$182.24 - $241.7 $144,880 - $192,151	795 Added 7.12%	11,968 $2.43 Million
Q4 2019 Jan 13, 2020	BUY	$189.21 - $243.2 $145,880 - $187,507	771 Added 7.41%	11,173 $2.69 Million
Q3 2019 Oct 17, 2019	SELL	$174.11 - $208.62 $45,268 - $54,241	-260 Reduced 2.44%	10,402 $2.01 Million
Q2 2019 Jul 23, 2019	SELL	$166.7 - $195.41 $60,011 - $70,347	-360 Reduced 3.27%	10,662 $1.97 Million
Q1 2019 May 06, 2019	BUY	$180.87 - $203.88 $84,104 - $94,804	465 Added 4.4%	11,022 $2.09 Million
Q4 2018 Jan 25, 2019	SELL	$178.4 - $208.25 $56,196 - $65,598	-315 Reduced 2.9%	10,557 $2.06 Million
Q3 2018 Oct 22, 2018	BUY	$185.29 - $208.89 $12,043 - $13,577	65 Added 0.6%	10,872 $2.25 Million
Q2 2018 Jul 18, 2018	BUY	$166.05 - $186.51 $79,704 - $89,524	480 Added 4.65%	10,807 $2 Million
Q1 2018 Apr 17, 2018	BUY	$169.43 - $198.0 $66,924 - $78,210	395 Added 3.98%	10,327 $1.76 Million
Q4 2017 Jan 11, 2018	BUY	$168.79 - $188.59 $1.68 Million - $1.87 Million	9,932	9,932 $1.73 Million

Others Institutions Holding AMGN

# of Institutions

3,087

Shares Held

417M

Call Options Held

7.19M

Put Options Held

6.13M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $170B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Sawyer & Company, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Sawyer & Company, Inc with notifications on news.

Account

Sawyer & Company, Inc Amgen Inc Transaction History